Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins
Successful vaccine efforts countering the COVID-19 pandemic are centralized around the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein as viral antigen and have greatly reduced the morbidity and mortality associated with COVID-19. Since the start of this pandemic, SARS...
Saved in:
Published in | Frontiers in immunology Vol. 13; p. 1025500 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
24.10.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!